Click for best price
Rx Irritable Bowel Syndrome IBS Drugs Market Size, Share 2023
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months.
This report aims to provide a comprehensive presentation of the global market for Rx Irritable Bowel Syndrome (IBS) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rx Irritable Bowel Syndrome (IBS) Drugs. This report contains market size and forecasts of Rx Irritable Bowel Syndrome (IBS) Drugs in global, including the following market information:
Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Rx Irritable Bowel Syndrome (IBS) Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
IBS-D Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Rx Irritable Bowel Syndrome (IBS) Drugs include Ironwood Pharmaceuticals, Bausch Health, Takeda, Sebela Pharmaceuticals and Allergan, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rx Irritable Bowel Syndrome (IBS) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rx Irritable Bowel Syndrome (IBS) Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Segment Percentages, by Type, 2022 (%)
IBS-D Drugs
IBS-C Drugs
Others
Global Rx Irritable Bowel Syndrome (IBS) Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Segment Percentages, by Application, 2022 (%)
Women
Men
Global Rx Irritable Bowel Syndrome (IBS) Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rx Irritable Bowel Syndrome (IBS) Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Rx Irritable Bowel Syndrome (IBS) Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ironwood Pharmaceuticals
Bausch Health
Takeda
Sebela Pharmaceuticals
Allergan
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rx Irritable Bowel Syndrome (IBS) Drugs, market overview.
Chapter 2: Global Rx Irritable Bowel Syndrome (IBS) Drugs market size in revenue.
Chapter 3: Detailed analysis of Rx Irritable Bowel Syndrome (IBS) Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rx Irritable Bowel Syndrome (IBS) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Rx Irritable Bowel Syndrome (IBS) Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Overall Market Size
2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size: 2022 VS 2029
2.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rx Irritable Bowel Syndrome (IBS) Drugs Players in Global Market
3.2 Top Global Rx Irritable Bowel Syndrome (IBS) Drugs Companies Ranked by Revenue
3.3 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Companies
3.4 Top 3 and Top 5 Rx Irritable Bowel Syndrome (IBS) Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Rx Irritable Bowel Syndrome (IBS) Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rx Irritable Bowel Syndrome (IBS) Drugs Players in Global Market
3.6.1 List of Global Tier 1 Rx Irritable Bowel Syndrome (IBS) Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Rx Irritable Bowel Syndrome (IBS) Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Markets, 2022 & 2029
4.1.2 IBS-D Drugs
4.1.3 IBS-C Drugs
4.1.4 Others
4.2 By Type - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue & Forecasts
4.2.1 By Type - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, 2024-2029
4.2.3 By Type - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2022 & 2029
5.1.2 Women
5.1.3 Men
5.2 By Application - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue & Forecasts
5.2.1 By Application - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, 2018-2023
5.2.2 By Application - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, 2024-2029
5.2.3 By Application - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2022 & 2029
6.2 By Region - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue & Forecasts
6.2.1 By Region - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, 2024-2029
6.2.3 By Region - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, 2018-2029
6.3.2 US Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.3.3 Canada Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.3.4 Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, 2018-2029
6.4.2 Germany Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.4.3 France Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.4.4 U.K. Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.4.5 Italy Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.4.6 Russia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.4.8 Benelux Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, 2018-2029
6.5.2 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.5.3 Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.5.4 South Korea Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.5.6 India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, 2018-2029
6.6.2 Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.6.3 Argentina Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, 2018-2029
6.7.2 Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.7.3 Israel Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
6.7.5 UAE Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, 2018-2029
7 Rx Irritable Bowel Syndrome (IBS) Drugs Companies Profiles
7.1 Ironwood Pharmaceuticals
7.1.1 Ironwood Pharmaceuticals Company Summary
7.1.2 Ironwood Pharmaceuticals Business Overview
7.1.3 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Major Product Offerings
7.1.4 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in Global Market (2018-2023)
7.1.5 Ironwood Pharmaceuticals Key News & Latest Developments
7.2 Bausch Health
7.2.1 Bausch Health Company Summary
7.2.2 Bausch Health Business Overview
7.2.3 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Major Product Offerings
7.2.4 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in Global Market (2018-2023)
7.2.5 Bausch Health Key News & Latest Developments
7.3 Takeda
7.3.1 Takeda Company Summary
7.3.2 Takeda Business Overview
7.3.3 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Major Product Offerings
7.3.4 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in Global Market (2018-2023)
7.3.5 Takeda Key News & Latest Developments
7.4 Sebela Pharmaceuticals
7.4.1 Sebela Pharmaceuticals Company Summary
7.4.2 Sebela Pharmaceuticals Business Overview
7.4.3 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Major Product Offerings
7.4.4 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in Global Market (2018-2023)
7.4.5 Sebela Pharmaceuticals Key News & Latest Developments
7.5 Allergan
7.5.1 Allergan Company Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Major Product Offerings
7.5.4 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in Global Market (2018-2023)
7.5.5 Allergan Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Rx Irritable Bowel Syndrome (IBS) Drugs Market Opportunities & Trends in Global Market
Table 2. Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers in Global Market
Table 3. Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints in Global Market
Table 4. Key Players of Rx Irritable Bowel Syndrome (IBS) Drugs in Global Market
Table 5. Top Rx Irritable Bowel Syndrome (IBS) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Rx Irritable Bowel Syndrome (IBS) Drugs Product Type
Table 9. List of Global Tier 1 Rx Irritable Bowel Syndrome (IBS) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rx Irritable Bowel Syndrome (IBS) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Ironwood Pharmaceuticals Company Summary
Table 31. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product Offerings
Table 32. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Ironwood Pharmaceuticals Key News & Latest Developments
Table 34. Bausch Health Company Summary
Table 35. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Product Offerings
Table 36. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Bausch Health Key News & Latest Developments
Table 38. Takeda Company Summary
Table 39. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Product Offerings
Table 40. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Takeda Key News & Latest Developments
Table 42. Sebela Pharmaceuticals Company Summary
Table 43. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product Offerings
Table 44. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Sebela Pharmaceuticals Key News & Latest Developments
Table 46. Allergan Company Summary
Table 47. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Product Offerings
Table 48. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Allergan Key News & Latest Developments
List of Figures
Figure 1. Rx Irritable Bowel Syndrome (IBS) Drugs Segment by Type in 2022
Figure 2. Rx Irritable Bowel Syndrome (IBS) Drugs Segment by Application in 2022
Figure 3. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2022
Figure 8. By Type - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share, 2018-2029
Figure 16. US Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share, 2018-2029
Figure 28. China Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
